Skip to main content

CITADEL ADVISORS LLC

Position in HYPR — Hyperfine, Inc.

CIK 1423053 MIAMI, FL

Position in HYPR

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$0
-$10,761 QoQ
Shares Held
0
-100.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Sep 2022
10 quarters on record

Common Shares in HYPR Over Time

Shares Held

Position Value (USD)

Derivatives in HYPR

reported options exposure · as of Mar 31, 2026
CallValue
$15,660
CallShares
14,500
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Medical Devices

Healthcare · as of Mar 31, 2026

CITADEL ADVISORS LLC holds $1,870,037,695 across 83 Medical Devices names.

# Ticker Company Shares Value (USD) Open

All Filings in HYPR

Export CSV
18 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $15,660 14,500
2025-12-31 $10,761 10,992
2025-12-31 $29,467 30,100
2025-09-30 $38,280 26,400
2025-03-31 $286 400
2025-03-31 $11,957 16,700
2024-12-31 $1,848 2,100
2024-12-31 $9,104 10,346
2024-09-30 $13,674 12,662
2024-09-30 $1,188 1,100
2024-06-30 $37,429 44,035
2024-06-30 $765 900
2024-03-31 $2,700 2,700
2024-03-31 $55,128 55,128
2023-12-31 $163,034 145,567
2023-12-31 $672 600
2022-09-30 $56,747 70,059
2022-09-30 $11,664 14,400